NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Insamo

Insamo

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.insamo.com/

Last Round

Seed

Feb 21, 2024

Total Funding Raised

$12M

Company Overview

Insamo is a biotechnology company that specializes in the discovery of membrane-permeable and orally-available cyclic-peptides with antibody-like binding affinity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

macrocyclic drugsdrug discoverybiotechcomputational chemistrymolecular designAI drug discoverysynthetic chemistrymacrocyclesundruggable targetstherapeutic candidatesin silico drug designbiopharmadrug developmentpreclinical researchsmall molecule alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insamo Comparables

Compare Insamo with similar companies based on industry and business-model similarity.

Insamo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vilya
88%
BRT Biotechnologies
87%
Curve Therapeutics
86%

Insamo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 21, 2024

Key People

Founding team and executive leadership

Timothy Craven

Co-founder And CEO

Founding Team

Insamo Investors

Notable investors and investment history

Insamo Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Insamo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Insamo's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range15
Year Founded2022
Last FundingFeb 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.